Abstract:Background:It has been reported that curcumin could inhibit trinitrobenzene sulphonic acid(TNBS)-induced colitis in rats by activating peroxisome proliferator-activated receptor(PPAR)-γ.Aims:To investigate the antiinflammatory mechanism of curcumin in experimental colitis in rats by treating the colitis model in rats with curcumin,GW9662(an antagonist of PPAR-γ) and combination of these two agents.Methods:Colitis model in rats was established by instillation of TNBS/ethanol solution into rectum.After intraperitoneal injection of dimethyl sulfoxide(DMSO),curcumin,GW9662 or GW9662+curcumin,respectively for two weeks,the mortality rate,score of mucosal damage,serum levels of proinflammatory cytokine interleukin(IL)-2,antiinflammatory cytokine IL-10,colonic expression of PPAR-γ and nuclear factor(NF)-κB were determined and appraised.Results:As compared with the model control group,the mortality rate,macroscopic and histological score of colon mucosa,serum level of IL-2 and colonic expression of NF-κB in curcumin group were significantly decreased,and serum level of IL-10 and colonic expression of PPAR-γ significantly increased(P<0.05);no significant improvement of colonic inflammation was observed in GW9662+curcumin group.Expression of PPAR-γ was negatively correlated with expression of NF-κB in the normal control,model control and curcumin groups(P<0.01).Conclusions:Curcumin can exert antiinflammatory effect on colitis in rats induced by TNBS partially via PPAR-γ activation and subsequent down-regulation of NF-κB.

Antiinflammatory Effect of Curcumin on Experimental Colitis in Rats via Peroxisome Proliferator-activated Receptor-γ